Sains Malaysiana 47(8)(2018): 1811–1818
http://dx.doi.org/10.17576/jsm-2018-4708-20
Risk Factors of Gastric Premalignant
Lesion in Gastritis Patients
(Faktor Risiko Lesi Gastrik Premalignan pada
Pesakit Gastritis)
GONTAR ALAMSYAH SIREGAR1*, IDA PARWATI2, TRI HANGGONO ACHMAD3
& YONI FUADAH SYUKRIANI4
1Division of Gastroentero-Hepatology, Department
of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Jl. Dr.
T. Mansur No.5, Kampus USU, Medan 20155, Indonesia
2Department of Clinical Pathology, Faculty
of Medicine, Universitas Padjadjaran, Jl. Raya Bandung Sumedang KM 21, Jatinangor
45363, Bandung, Indonesia
3Department of Biochemistry, Faculty of
Medicine, Universitas Padjadjaran, Jl. Raya Bandung Sumedang KM 21, Jatinangor 45363,
Bandung, Indonesia
4Department of Forensic and Legal Medicine, Faculty of
Medicine, Universitas Padjadjaran, Jl. Raya Bandung Sumedang KM 21, Jatinangor
45363, Bandung, Indonesia
Diserahkan: 15 Januari 2018/Diterima: 23
April 2018
ABSTRACT
Gastric cancer is the second leading
cause of cancer-related mortality and the fourth most common cancer globally.
Gastric premalignant lesions are well known risk factors for the development of
gastric cancer. The purpose of this study was to investigate the risk factors
of gastric premalignant lesion. This cross-sectional study observed gastritis
patients at Adam Malik General Hospital, Permata Bunda General Hospital,
Universitas Sumatera Utara Hospital, all located in Medan, Indonesia. A total
of 120 gastritis patients were included in this study. Patients were
interviewed with a questionnaire to obtain demographic data, alcohol intake,
smoking status, high salt diet and NSAID use. Diagnosis of Helicobacter
pylori infection was made using positive results of the carbon-14 urea
breath test (14C-UBT), rapid urease test, and/or
immunohistochemistry. Endoscopy and biopsy were conducted to diagnose gastric
premalignant lesion. Gastric premalignant lesion diagnosis was made when one or
more of the following were present: Chronic atrophic gastritis, intestinal
metaplasia, or dysplasia. Data were analysed using SPSS version
22. There were 35/120 (29.2%) of gastritis patients having gastric premalignant
lesion. Multivariate analysis has shown that H. pylori infection,
patients with family history of gastric cancer, alcohol consumption and Batak
ethnic have increased risk to develop gastric premalignant lesion (p<0.05).
All these results implied that risk factors of gastric premalignant lesion were H. pylori infection, family history of gastric cancer, alcohol intake
and Batak ethnic.
Keywords: Gastric cancer; gastric
premalignant lesion; Helicobacter pylori; risk factors
ABSTRAK
Kanser gastrik merupakan penyebab kedua
terbesar dalam kejadian kematian berkaitan dengan kanser dan berada
di tempat keempat dalam kejadian kanser yang paling sering terjadi
di seluruh dunia. Faktor risiko yang terkenal dalam perkembangan
kanser gastrik adalah lesi gastrik premalignan. Objektif penyelidikan
ini adalah untuk mengkaji faktor risiko kejadian lesi gastrik premalignan.
Kajian keratan rentas ini dilakukan pada pesakit gastritis di hospital
yang berlokasi di Medan, Indonesia seperti Hospital Umum Adam Malik,
Hospital Umum Permata Bunda dan Hospital Universiti Sumatera Utara.
Jumlah pesakit gastriris yang terlibat dalam penyelidikan ini adalah
seramai 120 orang. Pesakit ditemu duga dengan soal selidik yang
merangkumi pertanyaan mengenai data demografi, pengunaan alkohol,
status penghisapan rokok, diet yang mengandungi garam tinggi serta
penggunaan ubat NSAID.
Diagnosis pada infeksi Helicobacter pylori ditentukan daripada hasil
positif pada ujian karbon-14 pernafasan urea (14C-UBT),
ujian pantas urease dan/atau immunohistokimia. Endoskopi dan biopsi
dijalankan untuk pendiagnosisan lesi gastrik premalignan. Diagnosis
lesi gastrik premalignan dilakukan sekiranya salah satu daripada
lesi ini ditemui: Gastritis atrofik kronik dan/atau metaplasia atau
displasia usus. Data dianalisis dengan menggunakan SPSS versi 22. 35 daripada 120 (29.2%) pesakit gastritis
mempunyai lesi gastrik premalignan. Analisis secara multivariat
menunjukkan bahawa infeksi H. pylori, pesakit dengan sejarah
keluarga kanser gastrik, penggunaan alkohol serta etnik Batak didapati
meningkatkan risiko perkembangan lesi gastrik premalignan (p<0.05).
Kesimpulannya, keputusan kajian menunjukkan bahawa faktor risiko
terjadinya lesi gastrik premalignan adalah infeksi H. pylori,
pesakit dengan sejarah keluarga kanser gastrik, penggunaan alkohol
dan etnik Batak.
Kata
kunci: Faktor risiko; Helicobacter pylori; kanser gastrik; lesi gastrik premalignant
RUJUKAN
Adlekha, S.,
Chadha, T., Krishnan, P. & Sumangala, B. 2013. Prevalence of Helicobacter
pylori infection among patients undergoing upper gastrointestinal endoscopy
in a Medical College Hospital in Kerala, India. Annals of Medical and Health
Sciences Research 3(4): 559-563.
Almouradi,
T., Hiatt, T. & Attar, B. 2013. Gastric intestinal metaplasia in an
underserved population in the USA: prevalence, epidemiologic, and clinical features. Gastroenterology Research and Practice 2013: Article ID. 856256.
Ambarsari,
F. & Widodo, P. 2012. Implementasi unsur tradisi dan kebudayaan Batak
dengan pendekatan modern dalam perancangan interior Museum Ulos Sumatera Utara. Interior Design 1(1): 1-6.
Ang, T.L.
& Fock, K.M. 2014. Clinical epidemiology of gastric cancer. Singapore
Medical Journal 55(12): 621-628.
Bedoya, A.,
Sanson, F., Fuertes, Y.Y., Santacruz, C., Cifuentes, Y., Calvache, D. &
Bedoya, A. 2012. Prevalence and severity of gastric cancer precursor lesions in
a high risk area. Revista Colombiana de Gastroenterologia 27(4):
274-280.
Benberin,
V., Bektayeva, R., Karabayeva, R., Lebedev, A., Akemeyeva, K., Paloheimo, L.
& Syrjanen, K. 2013. Prevalence of H. pylori infection and atrophic
gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital
based screening study using a panel of serum biomarkers. Anticancer Research 33: 4595-4602.
Bilman,
F.B., Ozdemir, M., Baysal, B. & Kurtoglu, M.G. 2016. Prevalence of H.
pylori in gastric biopsy specimen in the southeastern region of Turkey. Journal
of Infection in Developing Countries 10(11): 1177-1182.
Cheung, D.Y.
2017. Atrophic gastritis increases the risk of gastric cancer in asymptomatic
population in Korea. Gut Liver 11(5): 575-576.
Crew, K.D.
& Neugut, A.I. 2016. Epidemiology of gastric cancer. World Journal of
Gastroenterology 12(3): 354-362.
De Vries,
A.C., Meijer, G.A., Looman, C.W., Casparie, M.K., Hansen, B.E., van Grieken,
N.C. & Kuipers, E.J. 2007. Epidemiological trends of premalignant gastric
lesions: A long-term nationwide study in The Netherlands. Gut 56:
1665-1670.
De Vries,
A.C., van Grieken, N.C., Looman, C.W., Casparie, M.K., de Vries, E., Meijer,
G.A. & Kuipers, E.J. 2008. Gastric cancer risk in patients with
premalignant gastric lesions: A nationwide cohort study in The Netherlands. Gastroenterology 134(4): 945-952.
Den Hoed,
C.M., van Eijck, B.C., Capelle, L.G., van Dekken, H., Biermann, K., Siersema,
P.D. & Kuipers, E.J. 2011. The prevalence of premalignant gastric lesions
in asymptomatic patients: Predicting the future incidence of gastric cancer. European
Journal of Cancer 47: 1211-1218.
El-Omar,
E.M., Oien, K., Murray, L.S., El-Nujumi, A., Wirz, A., Gillen, D., Williams,
C., Fullarton, G. & McColl, K.E. 2000. Increased prevalence of precancerous
changes in relatives of gastric cancer patients: Critical role of H. pylori. Gastroenterology 118(1): 22-30.
Felley, C.,
Bouzourene, H., VanMelle, M.B., Hadengue, A., Michetti, P., Dorta, G., Spahr,
L., Giostra, E. & Frossard, J.L. 2012. Age, smoking and overweight
contribute to the development of intestinal metaplasia of the cardia. World
Journal of Gastroenterology 18: 2076-2083.
Ferlay, J.,
Parkin, D.M. & Steliarova-Foucher, E. 2010. Estimates of cancer incidence
and mortality in Europe in 2008. European Journal of Cancer 46: 765-781.
Gaol, N.L.
& Husin, S. 2013. Dilema pemberantasan minuman keras terhadap pelestarian
budaya masyarakat Batak Toba (studi kasus di Desa Ria-Ria Kecamatan Pollung Kabupaten
Humbang Hasundutan). Citizenship 1: 101-121.
Haziri, A.,
Shkololli, A.J., Gashi, Z., Berisha, D. & Haziri, A. 2010. Helicobacter
pylori infection and precancerous lesions of the stomach. Medicinski.
Arhiv. 64: 248-249.
Hu, B.,
Hajj, N.E., Sittler, S., Lammert, N., Barnes, R. & Meloni-Ehrig, A. 2012.
Gastric cancer: Classification, histology, and application of molecular
pathology. Journal of Gastrointestinal Oncology 3(3): 251-261.
Ishaq, S.
& Nunn, L. 2015. Helicobacter pylori and gastric cancer: A state of
the art review. Gastroenterology and Hepatology from Bed to Bench 8:
S6-14.
Joo, Y.E.,
Park, H.K., Myung, D.S., Baik, G.H., Shin, J.E., Seo, G.S., Kim, G.H., Kim,
H.Y., Cho, S.I. & Kim, N. 2013. Prevalence and risk factors of atrophic
gastritis and intestinal metaplasia: A nationwide multicenter prospective study
in Korea. Gut Liver 7: 303-310.
Karim-Kos,
H.E., de Vries, E., Soerjomataram, I., Lemmens, V., Siesling, S. &
Coebergh, J.W. 2008. Recent trends of cancer in Europe: A combined approach of
incidence, survival and mortality for 17 cancer sites since the 1990s. European
Journal of Cancer 44: 1345-1389.
Karimi, P.,
Islami, F., Anandasabapathy, S., Freedman, N.D. & Kamangar, F. 2014.
Gastric cancer: Descriptive epidemiology, risk factors, screening, and
prevention. Cancer Epidemiology, Biomarkers & Prevention 23(5):
700-713.
Kim, N.,
Park, Y.S., Cho, S.I., Lee, H.S., Choe, G., Kim, I.W., Won, Y.D., Park, J.H.,
Kim, J.S., Jung, H.C. & Song, I.S. 2008. Prevalence and risk factors of atrophic
gastritis and intestinal metaplasia in a Korean population without significant
gastro-duodenal disease. Helicobacter 13: 245- 255.
Kusters,
J.G., van Vliet, A.H. & Kuipers, E.J. 2006. Pathogenesis of Helicobacter
pylori infection. Clinical Microbiology Reviews 19(3): 449-490.
Lage, J., Uedo, N., Dinis-Ribeiro, M. & Yao, K. 2016.
Surveillance of patients with gastric precancerous conditions. Best Practice
& Research Clinical Gastroenterology 30(6): 913-922.
Li, H., Ma, L., Chen,
J., Zen, W., Jin, L., Xu, X., Xu, C. & Li, Y. 2016. ZJU index is associated
with prevalence of Helicobacter pylori infection in a Chinese
population. International Journal of Clinical and Experimental Medicine 9(11):
22324-22330.
Liu, J., Sun, L., Gong,
Y. & Yuan, Y. 2010. Risk factors of precancerous gastric lesions in a
population at high risk of gastric cancer. Chinese Journal of Cancer
Research 22(4): 267-273.
Malik, T.H., Zhao, C.,
Al-Ahmed, J.M., Alam, S.A. & Xu, H. 2017. Gastric intestinal metaplasia is
the most common histopathological phenotype among endoscopically diagnosed
atrophic gastritis patients in North-East China. Open Journal of
Gastroenterology 7: 65-74.
Mansour-Ghanaei, F.,
Joukar, F., Soati, F., Mansour-Ghanaei, A. & Atrkar-Roushan, Z. 2013.
Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia
in Guilan Province, North Iran. Asian Pacific Journal of Cancer Prevention 14(6):
3549-3554.
Maran, S., Lee, Y.Y.,
Xu, S., Rajab, N., Hasan, N., Aziz, S.H., Majid, N.A. & Zilfalil, B.A. 2013.
Gastric precancerous lesions are associated with gene variants in Helicobacter
pylori-susceptible ethnic Malays. World Journal of Gastroenterology 19(23):
3615-3622.
Masjedizadeh, A.R.,
Fathizadeh, P., Syahyesteh, A.A., Alavinejad, P., Hashemi, J. & Hajiani, E.
2013. Prevalence of H. pylori infection and precancerous gastric lesion
in family relative of gastric cancer in South West of Iran. Journal of
Gastroenterology and Hepatology Research 2(11): 878-882.
Nishino, Y., Inoue, M.,
Tsuji, I., Wakai, K., Nagata, C., Mizoue, T., Tanaka, K. & Tsugane, S.
2006. Tobacco smoking and gastric cancer risk: An evaluation based on a
systematic review of epidemiologic evidence among the Japanese population. Japanese
Journal of Clinical Oncology 36: 800-807.
Nomura, A.M., Wilkens,
L.R., Henderson, B.E., Epplein, M. & Kolonel, L.N. 2012. The association of
cigarette smoking with gastric cancer: The multiethnic cohort study. Cancer
Causes Control 23(1): 51-58.
Park, Y.H. & Kim, N.
2015. Review of atrophic gastritis and intestinal metaplasia as a premalignant
lesion of gastric cancer. Journal of Cancer Prevention 20(1): 25-40.
Rahman, R., Asombang,
A.W. & Ibdah, J.A. 2014. Characteristics of gastric cancer in Asia. World
Journal of Gastroenterology 20(16): 4483-4490.
Rojborwonwitaya, J.
& Vijitjunykul, N. 2005. Comparison of the accuracy of two commercial rapid
urase tests, CLOtest® and pronto dry®, in detecting Helicobacter pylori infection. Thai Journal of Gastroenterology 6(2): 55-60.
Rokkas, T., Sechopoulos,
P., Pistiolas, D., Margantinis, G. & Koukoulis, G. 2010. Helicobacter
pylori infection and gastric histology in first-degree relatives of gastric
cancer patients: A meta-analysis. European Journal of Gastroenterology &
Hepatology 22(9): 1128-1133.
Roman, L.D., Lukyanchuk,
R., Sablin, O.A., Araslanova, E.I., Eklund, C., Hendolin, P., Paloheimo, L.
& Syrjanen, K. 2016. Prevalence of H. pylori infection and atrophic
gastritis in a population-based screening with serum biomarker panel
(GastroPanel®) in St. Petersburg. Anticancer Research 36: 4129-4138.
Shin, C.M., Kim, N.,
Yang, H.J., Cho, S.I., Lee, H.S., Kim, J.S., Jung, H.C. & Song, I.S. 2010.
Stomach cancer risk in gastric cancer relatives: Interaction between Helicobacter
pylori infection and family history of gastric cancer for the risk of
stomach cancer. Journal of Clinical Gastroenterology 44(2):
e34-39.
Shiota, S., Cruz, M.,
Abreu, J.A.J., Mitsui, T., Terao, H., Disla, M., Iwatani, S., Nagashima, H.,
Matsuda, M., Uchida, T., Tronilo, L., Rodriguez, E. & Yamaoka, Y. 2014.
Virulence genes of Helicobacter pylori in the Dominican Republic. Journal
of Medical Microbiology 63: 1189-1196.
Song, H., Ekheden, I.G.,
Zheng, Z., Ericsson, J., Nyren, O. & Ye, W. 2015. Incidence of gastric
cancer among patients with gastric precancerous lesions: Observational cohort
study in a low risk Western population. British Medical Journal 351:
1-7.
Syam, A.F.,
Miftahussurur, M., Makmun, D., Nusi, I.A., Zain, L.H., Zulkhairi., Akil, F.,
Uswan, W.B., Simanjuntak, D., Uchida, T., Adi, P., Utari, A.P., Rezkitha, Y.A.,
Subsomwong, P., Nasronudin, Suzuki, R. & Yamaoka, Y. 2015. Risk factors and
prevalence of Helicobacter pylori in five largest islands of Indonesia:
A preliminary study. PLoS ONE 10(11): e0140186.
Szoke, D. 2009. Genetic
factors related to the histological and macroscopic lesions of the stomach.
Budapest: Semmelweis University. pp. 7-61 (Unpublished).
Tan, P. & Yeoh, K.
2015. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology 149(5): 1153- 1162.
Trindade, L.M., Menezes,
L.B., de Souza Neta, A.M., Leite Rolemberg, P.C., Souza, L.D., Barreto, I.D.
& Meurer, L. 2017. Prevalence of Helicobacter pylori infection in
samples of gastric biopsies. Gastroenterology Research 10(1): 33-41.
Weck, M.N. &
Brenner, H. 2006. Prevalence of chronic atrophic gastritis in different parts
of the world. Cancer Epidemiology, Biomarkers & Prevention 15:
1083-1094.
Wu, Y., Fan, Y., Jiang,
Y., Wang, Y., Liu, H. & Wei, M. 2013. Analysis of risk factors associated
with precancerous lesion of gastric cancer in patients from Eastern China: A
comparative study. Journal of Cancer Research and Therapeutics 9(2):
205-209.
Yashima, K., Sasaki, S.,
Koda, M., Kawaguchi, K., Harada, K. & Murawaki, Y. 2010. Premalignant lesions
in gastric cancer. Clinical Journal of Gastroenterology 3(1): 6-12.
Yeh, L.Y., Raj, M.,
Hassan, S., Aziz, S.A., Othman, N.H., Mutum, S.S. & Naik,V.R. 2009. Chronic
atrophic antral gastritis and risk of metaplasia and dysplasia in an area with
low prevalence of Helicobacter pylori. Indian Journal of Gastroenterology 28(2): 49-52.
Zali, H.,
Rezaei-Tavirani, M. & Azodi, M. 2011. Gastric cancer: Prevention, risk
factors, and treatment. Gastroenterology and Hepatology from Bed to Bench 4(4):
175-185.
Zhang, X.Y., Zhang, P.Y.
& Aboul-Soud, M.A.M. 2017. From inflammation to gastric cancer: Role of Helicobacter
pylori. Oncology Letters 13: 543-548.
Zhou, J., Teng, R., Xu,
C., Wang, Q., Guo, J., Xu, C., Li, Z., Xie, S., Shen, J. & Wang, L. 2013.
Overexpression of ERalpha inhibits proliferation and invasion of MKN28 gastric
cancer cells by suppressing beta-catenin. Oncology Reports 30:
1622-1630.
Zullo, A., Hassan, C.,
Romiti, A., Giusto, M., Guerriero, C., Lorenzetti, R., Campo, M.A. & Tomao,
S. 2012. Follow-up intestinal metaplasia in the stomach: When, how, and why. World
Journal of Gastrointestinal Oncology 4(3): 30-36.
*Pengarang untuk
surat-menyurat; email: gontarsir@gmail.com
|